Treatment of Burkitt's tumor with cyclophosphamide.
D000008:Abdominal Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D000328:Adult; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology; D002051:Burkitt Lymphoma / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D002648:Child; D003391:Cranial Nerves; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008339:Mandibular Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D014454:Uganda; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate